HealthEquity

HealthEquity, Inc. provides range of solutions for managing health care accounts. The firm’s offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Earnings data Q4 2025

HQY reports strong Q1 performance, faces challenges in seasonality and yield expectations

HQY's Q1 performance reflects strong growth and positive financial results, driven by increased HSA adoption and employer interest. However, the company faces challenges related to seasonality and yield expectations. To capitalize on opportunities, HQY should focus on reaching its enhanced rates target and addressing service fee pressures.

HealthEquity reports robust Q2 performance and eyes market expansion

HealthEquity's strong Q2 performance, driven by revenue and EBITDA growth, is supported by the enhanced rates product and expanded network partner footprint. While facing short-term challenges in interchange revenue and M&A environment changes, the company is well-positioned to capitalize on opportunities presented by market dynamics and regulatory discussions.

HealthEquity reports robust Q3 performance and optimistic fiscal '25 outlook

HealthEquity's Q3 performance showcased strong financial results, with raised fiscal '24 guidance and optimistic initial fiscal '25 guidance. The company is well-positioned to navigate challenges and capitalize on opportunities, particularly in expanding its market presence and enhancing customer satisfaction.

HealthEquity (HQY) posts record earnings, eyes growth through innovation

HealthEquity (HQY) delivered strong financial results, exceeding expectations and demonstrating growth across key metrics.
While facing challenges in certain business segments, the company's focus on technology, customer experience, and long-term quality positions it well for the future.
Opportunities for R&D acceleration, innovation through M&A, and expansion of product offerings present avenues for sustained growth and competitive advantage.

HealthEquity reports robust Q1 results, raises fiscal '24 guidance

HealthEquity's Q1 performance reflects strong financial growth and stability, with revenue, EBITDA, and HSA metrics showing positive trends.
The company's proactive approach to guidance revision, service fee optimization, and strategic partnerships positions it well for future success.
Challenges in managing fee pressures, COBRA impact, and M&A environment slowdown require focused strategies for sustained growth and market leadership.

HealthEquity reports robust Q2 results, eyes growth amid market shifts

HealthEquity's Q2 results reflect strong financial performance and strategic positioning for future growth.
Despite challenges in revenue consistency and market dynamics, the company's strengths in service quality and market leadership are key assets.
Opportunities in revenue growth, legislative changes, and market demand provide avenues for HealthEquity's continued success.

HealthEquity reports strong Q3 growth and bullish outlook for fiscal '25

HealthEquity's Q3 2024 earnings call highlighted impressive financial performance, strategic acquisitions, and optimistic guidance for fiscal '25, underlining the company's growth trajectory and market positioning.
While facing challenges in integrating acquisitions, maintaining competitive pricing, and managing asset maturation, HealthEquity remains focused on growth opportunities through enhanced yield products and consumer empowerment.
The company's emphasis on stability, profitability, and reinvestments, coupled with a proactive approach to engaging investors, sets the stage for continued success and market differentiation in the evolving healthcare landscape.

HealthEquity reports robust Q4 earnings, eyes growth through innovation

HealthEquity delivered strong financial results in Q4 2024, showcasing robust revenue growth and operational performance.
The company's focus on enhancing shareholder value, strategic mergers, and technology investments positions it well for future growth.
Challenges in pricing pressures and technology spend trends require careful navigation, while opportunities in HSA cash rates and digital innovations offer avenues for expansion.
Overall, HealthEquity's performance highlights resilience, strategic foresight, and a commitment to driving long-term value for stakeholders.

HealthEquity reports robust Q1 results, eyes cost savings and growth

HealthEquity's Q1 performance reflects strong growth in revenue, EBITDA, and HSA assets, underlining its market strength and operational efficiency.
The company's focus on cost savings, customer experience enhancement, and new sales growth positions it well for future success and market expansion.
While facing challenges in transitioning processes and managing costs, HealthEquity is leveraging opportunities in technology and market expansion to drive continued growth.

HealthEquity reports robust Q2 growth, unveils innovative healthcare payment options

HealthEquity's Q2 performance reflects strong growth and strategic initiatives to enhance healthcare payment options.
While facing challenges in margins and market conditions, the company's focus on innovation and team efforts bode well for future success.
Opportunities lie in leveraging HPAs, digital integration, and market expansion to drive continued growth and customer value.
Overall, HealthEquity's performance and outlook demonstrate resilience and a commitment to driving healthcare financial solutions.

HealthEquity reports robust Q3 growth amidst challenges and opportunities

HealthEquity's Q3 performance reflects strong growth and market positioning, despite challenges in gross profit margins.
The company's focus on legislative support, technology utilization, and diversified revenue streams positions it well for future expansion.
Opportunities in expanding the TAM, enhancing service delivery, and leveraging commuter offerings indicate a promising outlook for HealthEquity.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Allscripts Healthcare Solutions

Tabula Rasa Healthcare

Veeva Systems

Health IT stocks like HealthEquity (HQY), Veeva Systems (VEEV), Tabula Rasa (TRHC) and Allscripts (MDRX) are expected to continue their run over the next few months.

MedTech Thrives on Healthcare IT in 2021: 4 Stocks to Focus on

HealthEquity (HQY) reported earnings 30 days ago. What's next for the stock?

Why Is HealthEquity (HQY) Down 0.7% Since Last Earnings Report?

DRAPER, Utah, June 22, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY), the nation's largest health savings account ("HSA") non-bank custodian, today announced that CEO Jon Kessler has been awarded a Glassdoor Employees' Choice Award honoring the Top CEOs in 2021.

Glassdoor Names HealthEquity's Jon Kessler A 2021 Top CEO

Investors continue to be optimistic about HealthEquity (HQY) on its slew of buyouts and strength in HSA.

Reasons to Add HealthEquity Stock (HQY) to Your Portfolio

Euroseas

Oxford Industries

Transcat

Top Ranked Momentum Stocks to Buy for June 14th

HealthEquity (HQY) delivers solid growth in HSAs along with recording robust Interchange revenues in the first quarter of fiscal 2022.

HealthEquity (HQY) Q1 Earnings Beat Estimates, FY22 View Up

DRAPER, Utah, June 08, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") non-bank custodian, today announced an updated business outlook, superseding the business outlook announced by HealthEquity on June 7, 2021. The updated business outlook is being issued to exclude anticipated merger integration expenses related to the Further acquisition that were included in the previously announced business outlook.

HealthEquity Updates Business Outlook

HealthEquity, Inc.'s (HQY) CEO Jon Kessler on Q1 2022 Results - Earnings Call Transcript

Shares of HealthEquity (NASDAQ:HQY) were flat after the company reported Q1 results. Quarterly Results Earnings per share were down 11.63% year over year to $0.38, which beat the estimate of $0.32.

Recap: HealthEquity Q1 Earnings

HealthEquity Reports First Quarter Ended April 30, 2021 Financial Results

HealthEquity (HQY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: HealthEquity (HQY) Q1 Earnings Expected to Decline

Howard Hughes

NeoGenomics

StoneCo

Spotting bloated toxic stocks on a regular basis and abandoning them at the right time is one of the secrets to a winning investment strategy.

Don't Let These 4 Toxic Stocks Erode Your Wealth

Is HealthEquity Set Up to Exceed Expectations in 2021?

DRAPER, Utah, April 27, 2021 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent HSA custodian, today announced it has entered into a definitive agreement with Fifth Third Bank, National Association ("Fifth Third"), to transition custodianship of Fifth Third's health savings account (HSA) portfolio to HealthEquity.

Fifth Third Bank HSAs Moving to HealthEquity

DexCom

Las Vegas Sands

MercadoLibre

Steer clear of toxic stocks like MELI, HQY, DXCM, STNE and LVS to safeguard your portfolio.

5 Toxic Stocks That Could Break the Bank

HealthEquity is currently going through a slower growth period after seeing significant growth in recent years.

HealthEquity Looks To Resume Its Upward Trend After Recent Pullback

OLDWICK, N.J.--(BUSINESS WIRE)--AM Best has placed under review with negative implications the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb+” of MII Life Insurance, Incorporated (MII Life) (Eagan, MN). This Credit Rating (ratings) action follows the recent announcement that HealthEquity, Inc. [NASDAQ: HQY] has entered into an agreement to acquire MII Life for $500 million. The transaction is expected to close in the third quarter of 2021, subject to reg

AM Best Places Credit Ratings of MII Life Insurance, Incorporated Under Review With Negative Implications

HealthEquity (HQY) Down 13.1% Since Last Earnings Report: Can It Rebound?

HealthEquity Inc (NASDAQ: HQY) has agreed to acquire Further, a health savings account provider (HSA) and consumer-directed benefit administration services for $500 million. The acquisition of Further and its technology reinforces HealthEquity's position in the HSA market and other go-to-market partners.

HealthEquity Scoops Up Further For $500M

Adds private-label capabilities, significant health plan relationships and VEBA solutions Adds private-label capabilities, significant health plan relationships and VEBA solutions

HealthEquity to Acquire Further

HealthEquity (HQY) delivers solid growth in HSAs and custodial assets in the fiscal fourth quarter.

HealthEquity (HQY) Q4 Earnings, Revenues Beat Estimates

The problem came with the HSA provider's full-year guidance.

Why HealthEquity's Better-Than-Expected Q4 Results Didn't Excite Investors

HealthEquity, Inc. (HQY) CEO Jon Kessler on Q4 2021 Results - Earnings Call Transcript

HealthEquity (HQY) delivered earnings and revenue surprises of 2.44% and 1.40%, respectively, for the quarter ended January 2021. Do the numbers hold clues to what lies ahead for the stock?

HealthEquity (HQY) Q4 Earnings and Revenues Surpass Estimates

Shares of HealthEquity (NASDAQ:HQY) decreased in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 7.69% year over year to $0.42, which beat the estimate of $0.39.

News for HealthEquity Stock (HQY)